United States Prostate Cancer Drugs Market Report 2016

Publisher Name :
Date: 18-Sep-2016
No. of pages: 115
Inquire Before Buying

Notes:

Sales, means the sales volume of Prostate Cancer Drugs

Revenue, means the sales value of Prostate Cancer Drugs

This report studies sales (consumption) of Prostate Cancer Drugs in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering

- Abbvie

- Astra Zeneca

- Janssen Pharmaceuticals

- Sanofi

- Amgen

- Astellas Pharma

- Bayer

- BMS

- Dendreon

- Endo Pharmaceuticals

- Ferring Pharmaceutical

Split by product Types, with sales, revenue, price, market share and growth rate of each type, can be divided into

- Type I

- Type II

- Type III

Split by applications, this report focuses on sales, market share and growth rate of Prostate Cancer Drugs in each application, can be divided into

- Application 1

- Application 2

- Application 3

United States Prostate Cancer Drugs Market Report 2016

Table of Contents
United States Prostate Cancer Drugs Market Report 2016
1 Prostate Cancer Drugs Overview
1.1 Product Overview and Scope of Prostate Cancer Drugs
1.2 Classification of Prostate Cancer Drugs
1.2.1 Type I
1.2.2 Type II
1.2.3 Type III
1.3 Application of Prostate Cancer Drugs
1.3.1 Application 1
1.3.2 Application 2
1.3.3 Application 3
1.4 United States Market Size Sales (Value) and Revenue (Volume) of Prostate Cancer Drugs (2011-2021)
1.4.1 United States Prostate Cancer Drugs Sales and Growth Rate (2011-2021)
1.4.2 United States Prostate Cancer Drugs Revenue and Growth Rate (2011-2021)
2 United States Prostate Cancer Drugs Competition by Manufacturers
2.1 United States Prostate Cancer Drugs Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Prostate Cancer Drugs Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Prostate Cancer Drugs Average Price by Manufactures (2015 and 2016)
2.4 Prostate Cancer Drugs Market Competitive Situation and Trends
2.4.1 Prostate Cancer Drugs Market Concentration Rate
2.4.2 Prostate Cancer Drugs Market Share of Top 3 and Top 5 Manufacturers
2.4.3 Mergers & Acquisitions, Expansion
3 United States Prostate Cancer Drugs Sales (Volume) and Revenue (Value) by Type (2011-2016)
3.1 United States Prostate Cancer Drugs Sales and Market Share by Type (2011-2016)
3.2 United States Prostate Cancer Drugs Revenue and Market Share by Type (2011-2016)
3.3 United States Prostate Cancer Drugs Price by Type (2011-2016)
3.4 United States Prostate Cancer Drugs Sales Growth Rate by Type (2011-2016)
4 United States Prostate Cancer Drugs Sales (Volume) by Application (2011-2016)
4.1 United States Prostate Cancer Drugs Sales and Market Share by Application (2011-2016)
4.2 United States Prostate Cancer Drugs Sales Growth Rate by Application (2011-2016)
4.3 Market Drivers and Opportunities
5 United States Prostate Cancer Drugs Manufacturers Profiles/Analysis
5.1 Abbvie
5.1.1 Company Basic Information, Manufacturing Base and Competitors
5.1.2 Prostate Cancer Drugs Product Type, Application and Specification
5.1.2.1 Type I
5.1.2.2 Type II
5.1.3 Abbvie Prostate Cancer Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
5.1.4 Main Business/Business Overview
5.2 Astra Zeneca
5.2.2 Prostate Cancer Drugs Product Type, Application and Specification
5.2.2.1 Type I
5.2.2.2 Type II
5.2.3 Astra Zeneca Prostate Cancer Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
5.2.4 Main Business/Business Overview
5.3 Janssen Pharmaceuticals
5.3.2 Prostate Cancer Drugs Product Type, Application and Specification
5.3.2.1 Type I
5.3.2.2 Type II
5.3.3 Janssen Pharmaceuticals Prostate Cancer Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
5.3.4 Main Business/Business Overview
5.4 Sanofi
5.4.2 Prostate Cancer Drugs Product Type, Application and Specification
5.4.2.1 Type I
5.4.2.2 Type II
5.4.3 Sanofi Prostate Cancer Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
5.4.4 Main Business/Business Overview
5.5 Amgen
5.5.2 Prostate Cancer Drugs Product Type, Application and Specification
5.5.2.1 Type I
5.5.2.2 Type II
5.5.3 Amgen Prostate Cancer Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
5.5.4 Main Business/Business Overview
5.6 Astellas Pharma
5.6.2 Prostate Cancer Drugs Product Type, Application and Specification
5.6.2.1 Type I
5.6.2.2 Type II
5.6.3 Astellas Pharma Prostate Cancer Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
5.6.4 Main Business/Business Overview
5.7 Bayer
5.7.2 Prostate Cancer Drugs Product Type, Application and Specification
5.7.2.1 Type I
5.7.2.2 Type II
5.7.3 Bayer Prostate Cancer Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
5.7.4 Main Business/Business Overview
5.8 BMS
5.8.2 Prostate Cancer Drugs Product Type, Application and Specification
5.8.2.1 Type I
5.8.2.2 Type II
5.8.3 BMS Prostate Cancer Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
5.8.4 Main Business/Business Overview
5.9 Dendreon
5.9.2 Prostate Cancer Drugs Product Type, Application and Specification
5.9.2.1 Type I
5.9.2.2 Type II
5.9.3 Dendreon Prostate Cancer Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
5.9.4 Main Business/Business Overview
5.10 Endo Pharmaceuticals
5.10.2 Prostate Cancer Drugs Product Type, Application and Specification
5.10.2.1 Type I
5.10.2.2 Type II
5.10.3 Endo Pharmaceuticals Prostate Cancer Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
5.10.4 Main Business/Business Overview
5.11 Ferring Pharmaceutical
6 Prostate Cancer Drugs Manufacturing Cost Analysis
6.1 Prostate Cancer Drugs Key Raw Materials Analysis
6.1.1 Key Raw Materials
6.1.2 Price Trend of Key Raw Materials
6.1.3 Key Suppliers of Raw Materials
6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
6.2.1 Raw Materials
6.2.2 Labor Cost
6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of Prostate Cancer Drugs
7 Industrial Chain, Sourcing Strategy and Downstream Buyers
7.1 Prostate Cancer Drugs Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of Prostate Cancer Drugs Major Manufacturers in 2015
7.4 Downstream Buyers
8 Marketing Strategy Analysis, Distributors/Traders
8.1 Marketing Channel
8.1.1 Direct Marketing
8.1.2 Indirect Marketing
8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
8.2.1 Pricing Strategy
8.2.2 Brand Strategy
8.2.3 Target Client
8.3 Distributors/Traders List
9 Market Effect Factors Analysis
9.1 Technology Progress/Risk
9.1.1 Substitutes Threat
9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change
10 United States Prostate Cancer Drugs Market Forecast (2016-2021)
10.1 United States Prostate Cancer Drugs Sales, Revenue Forecast (2016-2021)
10.2 United States Prostate Cancer Drugs Sales Forecast by Type (2016-2021)
10.3 United States Prostate Cancer Drugs Sales Forecast by Application (2016-2021)
10.4 Prostate Cancer Drugs Price Forecast (2016-2021)
11 Research Findings and Conclusion
12 Appendix
Author List
Disclosure Section
Research Methodology
Data Source
Disclaimer
List of Tables and Figures
Figure Picture of Prostate Cancer Drugs
Table Classification of Prostate Cancer Drugs
Figure United States Sales Market Share of Prostate Cancer Drugs by Type in 2015
Table Application of Prostate Cancer Drugs
Figure United States Sales Market Share of Prostate Cancer Drugs by Application in 2015
Figure United States Prostate Cancer Drugs Sales and Growth Rate (2011-2021)
Figure United States Prostate Cancer Drugs Revenue and Growth Rate (2011-2021)
Table United States Prostate Cancer Drugs Sales of Key Manufacturers (2015 and 2016)
Table United States Prostate Cancer Drugs Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Prostate Cancer Drugs Sales Share by Manufacturers
Figure 2016 Prostate Cancer Drugs Sales Share by Manufacturers
Table United States Prostate Cancer Drugs Revenue by Manufacturers (2015 and 2016)
Table United States Prostate Cancer Drugs Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Prostate Cancer Drugs Revenue Share by Manufacturers
Table 2016 United States Prostate Cancer Drugs Revenue Share by Manufacturers
Table United States Market Prostate Cancer Drugs Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Prostate Cancer Drugs Average Price of Key Manufacturers in 2015
Figure Prostate Cancer Drugs Market Share of Top 3 Manufacturers
Figure Prostate Cancer Drugs Market Share of Top 5 Manufacturers
Table United States Prostate Cancer Drugs Sales by Type (2011-2016)
Table United States Prostate Cancer Drugs Sales Share by Type (2011-2016)
Figure United States Prostate Cancer Drugs Sales Market Share by Type in 2015
Table United States Prostate Cancer Drugs Revenue and Market Share by Type (2011-2016)
Table United States Prostate Cancer Drugs Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Prostate Cancer Drugs by Type (2011-2016)
Table United States Prostate Cancer Drugs Price by Type (2011-2016)
Figure United States Prostate Cancer Drugs Sales Growth Rate by Type (2011-2016)
Table United States Prostate Cancer Drugs Sales by Application (2011-2016)
Table United States Prostate Cancer Drugs Sales Market Share by Application (2011-2016)
Figure United States Prostate Cancer Drugs Sales Market Share by Application in 2015
Table United States Prostate Cancer Drugs Sales Growth Rate by Application (2011-2016)
Figure United States Prostate Cancer Drugs Sales Growth Rate by Application (2011-2016)
Table Abbvie Basic Information List
Table Abbvie Prostate Cancer Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Abbvie Prostate Cancer Drugs Sales Market Share (2011-2016)
Table Astra Zeneca Basic Information List
Table Astra Zeneca Prostate Cancer Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Astra Zeneca Prostate Cancer Drugs Sales Market Share (2011-2016)
Table Janssen Pharmaceuticals Basic Information List
Table Janssen Pharmaceuticals Prostate Cancer Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Janssen Pharmaceuticals Prostate Cancer Drugs Sales Market Share (2011-2016)
Table Sanofi Basic Information List
Table Sanofi Prostate Cancer Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Sanofi Prostate Cancer Drugs Sales Market Share (2011-2016)
Table Amgen Basic Information List
Table Amgen Prostate Cancer Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Amgen Prostate Cancer Drugs Sales Market Share (2011-2016)
Table Astellas Pharma Basic Information List
Table Astellas Pharma Prostate Cancer Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Astellas Pharma Prostate Cancer Drugs Sales Market Share (2011-2016)
Table Bayer Basic Information List
Table Bayer Prostate Cancer Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Bayer Prostate Cancer Drugs Sales Market Share (2011-2016)
Table BMS Basic Information List
Table BMS Prostate Cancer Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table BMS Prostate Cancer Drugs Sales Market Share (2011-2016)
Table Dendreon Basic Information List
Table Dendreon Prostate Cancer Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Dendreon Prostate Cancer Drugs Sales Market Share (2011-2016)
Table Endo Pharmaceuticals Basic Information List
Table Endo Pharmaceuticals Prostate Cancer Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Endo Pharmaceuticals Prostate Cancer Drugs Sales Market Share (2011-2016)
Table Ferring Pharmaceutical Basic Information List
Table Ferring Pharmaceutical Prostate Cancer Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Ferring Pharmaceutical Prostate Cancer Drugs Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Prostate Cancer Drugs
Figure Manufacturing Process Analysis of Prostate Cancer Drugs
Figure Prostate Cancer Drugs Industrial Chain Analysis
Table Raw Materials Sources of Prostate Cancer Drugs Major Manufacturers in 2015
Table Major Buyers of Prostate Cancer Drugs
Table Distributors/Traders List
Figure United States Prostate Cancer Drugs Production and Growth Rate Forecast (2016-2021)
Figure United States Prostate Cancer Drugs Revenue and Growth Rate Forecast (2016-2021)
Table United States Prostate Cancer Drugs Production Forecast by Type (2016-2021)
Table United States Prostate Cancer Drugs Consumption Forecast by Application (2016-2021)
  • 2017-2022 Fibrin Glue Report on United States and Global Market, Status and Forecast, by Players, Types and Applications
    Published: 23-Mar-2017        Price: US 2922 Onwards        Pages: 126
    This report studies the Fibrin Glue on United States and global market, focuses on the top players in US market and also the market status and outlook by type and application. Geographically, this report is segmented into several key regions, with sales, revenue, market share (%) and growth Rate (%) of Fibrin Glue in these regions, from 2012 to 2022 (forecast), covering North America Europe Asia-Pacific South America Middle East and Africa ......
  • 2012-2022 Report on Global rhEPO Market Competition, Status and Forecast, Market Size by Players, Regions, Types, Applications
    Published: 23-Mar-2017        Price: US 3268 Onwards        Pages: 126
    This report studies the rhEPO market status and outlook of global and major regions, from angles of manufacturers, regions, product types and end industries; this report analyzes the top manufacturers in global and major regions, and splits the rhEPO market by product type and applications end industries. The global rhEPO market is valued at XX million USD in 2016 and is expected to reach XX million USD by the end of 2022, gOthering at a CAGR of XX% between 2016 and 2022. ......
  • 2012-2022 Report on Global Phosphatases Market Competition, Status and Forecast, Market Size by Players, Regions, Type, Application
    Published: 23-Mar-2017        Price: US 3268 Onwards        Pages: 104
    In this report, the global Phosphatases market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report split global into several key Regions, with sales (K Unit), revenue (Million USD), market share and growth rate of Phosphatases for these regions, from 2012 to 2022 (forecast), covering - United States - China - Europe - Japan - So......
  • 2012-2022 Report on Global Glass Ampoules Market Competition, Status and Forecast, Market Size by Players, Regions, Type, Application
    Published: 23-Mar-2017        Price: US 3268 Onwards        Pages: 116
    This report studies Glass Ampoules in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with capacity, production, price, revenue and market share for each manufacturer, covering Schott AG Becton Dickinson Gerresheimer AG Nipro Glass J.Penner Akey Group Hindustan National Glass Terumo Corp Medtronic Ypsomed Holding AG Market......
  • 2012-2022 Report on Global Cisapride Market Competition, Status and Forecast, Market Size by Players, Regions, Type, Application
    Published: 23-Mar-2017        Price: US 4568 Onwards        Pages: 129
    This report studies Cisapride in Global market, especially in Europe, North America, China, Japan, Korea, India, Southeast Asia and South America, focuses on top manufacturers in global market, with capacity, production, price, revenue and market share for each manufacturer. Manufacturers for Cisapride Janssen Pharmaceutical RxList The BMJ MedicineNet AAVPT PubChem Medscape Sigma-Aldrich NEJM Doctissimo......
  • 2012-2022 Report on Global Alzheimer's Disease Market Competition, Status and Forecast, Market Size by Players, Regions, Type, Application
    Published: 23-Mar-2017        Price: US 3268 Onwards        Pages: 104
    This report studies the Alzheimer's Disease Drug market status and outlook of global and major regions, from angles of players, regions, product types and end industries; this report analyzes the top players in global and major regions, and splits the Alzheimer's Disease Drug market by product type and applications end industries. In the last several years, global market of alzheimer's disease drug change huge. In 2016, global revenue of alzheimer's disease drug is nearly 3161.3 M......
  • Global Dunaliella Market Research Report 2017
    Published: 23-Mar-2017        Price: US 2900 Onwards        Pages: 110
    The Dunaliella industry concentration is high; in the world wide, giant manufacturers mainly distribute in Australia, China and Japan. Australia by virtue of the advantage of nature, has a long history and unshakable status in this industry, like Evolutionary Health, Plankton Australia Pty Ltd and Nutra-Kol both have perfect products. In China, the manufacturers focus in coastal region. As for consumption market, the global market sales were 1159 MT Dunaliella in 2016, which has been sta......
  • Ocular Hypertension - Pipeline Review, H1 2017
    Published: 22-Mar-2017        Price: US 2000 Onwards        Pages: 118
    Ocular Hypertension - Pipeline Review, H1 2017 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Ocular Hypertension - Pipeline Review, H1 2017, provides an overview of the Ocular Hypertension (Ophthalmology) pipeline landscape. Ocular hypertension occurs when the pressure inside the eye (intraocular pressure) is higher than normal. If the aqueous humor does not flow through the trabecular meshwork properly, ......
  • Periodontitis - Pipeline Review, H1 2017
    Published: 22-Mar-2017        Price: US 2000 Onwards        Pages: 48
    Periodontitis - Pipeline Review, H1 2017 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Periodontitis - Pipeline Review, H1 2017, provides an overview of the Periodontitis (Mouth And Dental Disorders) pipeline landscape. Periodontitis is a gum infection that damages the soft tissue and destroys the bone that supports teeth. Signs and symptoms of periodontitis include swollen gums, bright red or purplish gum......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs